KO

Krishnan Ohri

Director Director DIN 03616250
DIN 03616250 First appointment May 2012 Primary industry Internet
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2012
Shareholding value •••• Premium profile

About Krishnan Ohri

Data last updated:

Krishnan Ohri was a Director at Dream Serve Network Private Limited (2012–2020) and Director at Angus Eva Pharma Private Limited (2012–2019). The companies operate in Internet and Veterinary.

DIN 03616250
Primary Designation Director
Industry Internet
First Appointment 24 May 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dream Serve Network Private Limited U72100TN2004PTC054872
Director02 Aug 20122004₹80.6 Lakh (FY 2025)Active
Angus Eva Pharma Private Limited U24100TN2012PTC086031
Director24 May 20122012₹1.28 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dream Serve Network Private Limited
Angus Eva Pharma Private Limited
Premium access

Shareholding and investment profile for Krishnan Ohri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnan Ohri

Krishnan Ohri was first appointed on 24 May 2012 as Director at Angus Eva Pharma Private Limited.

Krishnan Ohri held 2 earlier board appointments: Dream Serve Network Private Limited (Director, 02 Aug 2012 to 01 Feb 2020); Angus Eva Pharma Private Limited (Director, 24 May 2012 to 01 Oct 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available